Clopidogrel

Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease.

Journal: Annals of medicine

Published: April 15, 2026

Sixty years of research into ancestry differences in platelet function.

Journal: Platelets

Published: April 07, 2026

Evaluation of Platelet Function Detection Using Sequential Platelet Counting Method via Fluorescent Platelet Channel.

Journal: Clinical laboratory

Published: April 07, 2026

Antiplatelet therapy in high-bleeding risk patients with acute coronary syndrome: pharmacogenomics in the era of precision medicine.

Journal: Pharmacogenomics

Published: March 30, 2026

Toward Optimal Antiplatelet Therapy in Acute Ischemic Stroke: What Can We Learn from a Post Hoc Subgroup Analysis of the ACUTE-PRAS Study?

Journal: Journal of atherosclerosis and thrombosis

Published: March 29, 2026

PPI-Clopidogrel Interaction: Can Claims Data Settle the Debate?

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: March 26, 2026

Hematuria-related readmission after transurethral resection of bladder tumor in patients receiving antiplatelet therapy.

Journal: Urologia

Published: March 21, 2026

Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial.

Journal: Cardiology in review

Published: March 20, 2026

Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort.

Journal: Circulation. Cardiovascular interventions

Published: March 18, 2026

Contemporary Trends in High-Potency P2Y12 Receptor Inhibitor Use Among Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Journal: Journal of the American Heart Association

Published: March 18, 2026

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes　- Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: March 18, 2026

Signal detection of drug-induced esophageal ulcer across 20 years of real-world study: Focus on 49 high-risk medicines.

Journal: The Journal of international medical research

Published: March 17, 2026

Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease.

Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease.

Sixty years of research into ancestry differences in platelet function.

Sixty years of research into ancestry differences in platelet function.

Evaluation of Platelet Function Detection Using Sequential Platelet Counting Method via Fluorescent Platelet Channel.

Evaluation of Platelet Function Detection Using Sequential Platelet Counting Method via Fluorescent Platelet Channel.

Antiplatelet therapy in high-bleeding risk patients with acute coronary syndrome: pharmacogenomics in the era of precision medicine.

Antiplatelet therapy in high-bleeding risk patients with acute coronary syndrome: pharmacogenomics in the era of precision medicine.

Toward Optimal Antiplatelet Therapy in Acute Ischemic Stroke: What Can We Learn from a Post Hoc Subgroup Analysis of the ACUTE-PRAS Study?

Toward Optimal Antiplatelet Therapy in Acute Ischemic Stroke: What Can We Learn from a Post Hoc Subgroup Analysis of the ACUTE-PRAS Study?

PPI-Clopidogrel Interaction: Can Claims Data Settle the Debate?

PPI-Clopidogrel Interaction: Can Claims Data Settle the Debate?

Hematuria-related readmission after transurethral resection of bladder tumor in patients receiving antiplatelet therapy.

Hematuria-related readmission after transurethral resection of bladder tumor in patients receiving antiplatelet therapy.

Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial.

Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial.

Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort.

Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total Cohort.

Contemporary Trends in High-Potency P2Y12 Receptor Inhibitor Use Among Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Contemporary Trends in High-Potency P2Y12 Receptor Inhibitor Use Among Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes - Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes - Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.

Signal detection of drug-induced esophageal ulcer across 20 years of real-world study: Focus on 49 high-risk medicines.

Signal detection of drug-induced esophageal ulcer across 20 years of real-world study: Focus on 49 high-risk medicines.

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes　- Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.

Aspirin vs. Clopidogrel Monotherapy Beyond 1 Month After Percutaneous Coronary Intervention in Patients With Diabetes　- Prespecified Subgroup Analysis of the STOPDAPT-3 Trial.